Lyell Immunopharma, Inc share price logo

Lyell Immunopharma, Inc Share Price

NASDAQ: LYEL

Small Cap

$12.85

-0.45

(-3.38%)

as on

Lyell Immunopharma, Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $12.68
    $13.23
    downward going graph

    1.32%

    Downside

    2.96%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.65
    $32
    downward going graph

    40.47%

    Downside

    149.03%

    Upside

    downward going graph

Lyell Immunopharma, Inc share price movements today

Previous Close
$13.30
Open
$13.05
Volume
134.2K
Day's Low - High
$12.68 - $13.23
52 Week Low - High
$7.65 - $32

Lyell Immunopharma, Inc Historical Returns

1 Month Return
+ 21.17 %
3 Month Return
+ 31.62 %
1 Year Return
-47.89 %
3 Year Return
-91.95 %
5 Year Return
0 %

Lyell Immunopharma, Inc Stock Fundamentals & Key Indicators

Check Lyell Immunopharma, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$246.3M

EPS (TTM)

-11.7633

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.78

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

0

EBITDA

-194.9M

Revenue (TTM)

60.0K

Profit Margin

0.00%

Return On Equity TTM

1012200.00%

Lyell Immunopharma, Inc Stock Valuation

Track how Lyell Immunopharma, Inc P/E has moved over time to understand its valuation trends.

Lyell Immunopharma, Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Today (-1.78x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.78x

Lyell Immunopharma, Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lyell Immunopharma, Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$246.3MNA-1.780.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Lyell Immunopharma, Inc Stock including INR - Dollar returns

The Lyell Immunopharma, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Lyell Immunopharma, Inc investment value today

Current value as on today

₹57,375

Returns

₹42,625

(-42.63%)

Returns from Lyell Immunopharma, Inc Stock

₹47,764 (-47.76%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Lyell Immunopharma, Inc Stock

Based on 10 analysts

BUY

70.00%

Buy

30.00%

Hold

0.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for Lyell Immunopharma, Inc. Average target price of $11

Lyell Immunopharma, Inc Share Price Target

Get share price movements and forecasts by analysts on Lyell Immunopharma, Inc.

What analysts predicted

-16.82%DOWNSIDE

Target Price

$11

Current Price

$12.85

Analyzed by

10 Analysts

Target

$11.00

Lyell Immunopharma, Inc target price $11, a slight downside of -16.82% compared to current price of $12.85. According to 10 analysts rating.

Lyell Immunopharma, Inc Stock's Interest Amongst Investors

Search interest for Lyell Immunopharma, Inc Stock has decreased by -82% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-82% versus previous 30 day period

Lyell Immunopharma, Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
-4
-4
-5
-5
0
0
0
0
0
0
Operating Income
-62
-65
-59
-59
-55
-51
-50
-201
-57
-47
EBITDA
-57
-60
-53
-54
-50
-46
-45
-57
-53
-42
Interest Expense
65
5
-
-
-
-
-
-
-
-
Depreciation
5
5
5
5
5
4
4
5
3
3
Income Before Tax
-66
-63
-50
-52
-60
-45
-44
-191
-52
-42
Income Tax Expense
65
-2
-6
5
4
-
-
-
-
-
Net Income
-132
-63
-50
-52
-60
-45
-44
-191
-52
-42
Net Profit Margin
-204046.15%
-236629.63%
-203412.00%
-407153.85%
-2022233.33%
-352376.92%
-131126.47%
-1744863.64%
-745642.86%
-533550.00%

Lyell Immunopharma, Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
7
10
84
0
0
Gross Profit
0
0
-3
68
0
0
Operating Income
-102
-211
-214
-183
-247
-358
EBITDA
-100
-207
-199
-166
-226
-200
Interest Expense
-
5
1
-
-
-
Depreciation
1
4
13
18
20
19
Income Before Tax
-129
-204
-250
-183
-234
-342
Income Tax Expense
-8
-5
35
-178
-10
-
Net Income
-121
-198
-285
-4
-234
-342
Net Profit Margin
-18456.01%
-2559.73%
-2680.76%
-5.61%
-180486.15%
-562285.25%

Lyell Immunopharma, Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-63
-50
-52
-60
-45
-44
-191
-52
-42
Operating Cash Flow
-39
-37
-40
-42
-38
-35
-47
-54
-34
Investing Cash Flow
152
99
-100
21
45
1
53
69
12
Financing Cash Flow
1
0
0
0
0
-
0
0
0
Change in Cash
114
61
-140
-19
7
-33
6
14
-21

Lyell Immunopharma, Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-204
-250
-183
-234
-342
Operating Cash Flow
-160
-126
-169
-163
-162
Investing Cash Flow
-273
-121
-11
184
122
Financing Cash Flow
476
401
10
1
1
Change in Cash
42
153
-170
22
-38

Global Institutional Holdings in Lyell Immunopharma, Inc

Funds
Holdings
MWG Management Ltd.
5.25%
Foresite Capital Management IV, LLC
4.17%
Orland Properties Ltd
3.93%
BlackRock Inc
3.31%
Decheng Capital LLC
3.1%

Insights on Lyell Immunopharma, Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -191.93M → -42.68M (in $), with an average increase of 145.0% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 7.0K → 8.0K (in $), with an average increase of 12.5% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, LYEL stock has moved up by 21.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 215.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 123.5%

About Lyell Immunopharma, Inc

we are entering a new era of medicine, where cancer is treated with cellular therapies: living, smart, targeted drugs. while enormous strides have been made, especially in hematologic cancers, the full promise of these therapies still lies ahead. cell-based immunotherapies have yet to show substantial benefit in solid tumors, which represent the vast majority of cancers. our goal is nothing less than to develop curative cell-based immunotherapies for any cancer, with a focus on car-ts and solid tumors.
OrganisationLyell Immunopharma, Inc
Headquarters201 Haskins Way, South San Francisco, CA, United States, 94080
IndustryServices
CEODr. Lynn Seely M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Lyell Immunopharma, Inc

Name

Title

Dr. Crystal L. Mackall M.D.

Founder & Scientific Advisor

Mr. Charles W. Newton

Chief Financial Officer

Nellie Dillery

Director of Accounting

Dr. Gary K. Lee Ph.D.

Chief Scientific Officer

Dr. Richard D. Klausner M.D.

Founder & Executive Chairman

Dr. Lynn Seely M.D., Ph.D.

President, CEO & Director

Mr. Stephen J. Hill

Chief Operating Officer

Prof. Stanley R. Riddell M.D.

Founder & Scientific Advisor

Mr. Matthew Lang J.D.

Advisor

Ms. Ellen Rose

Senior Vice President of Communications & Investor Relations

FAQs

What is Lyell Immunopharma, Inc share price today?

Lyell Immunopharma, Inc share price today is $12.85 as on at the close of the market. Lyell Immunopharma, Inc share today touched a day high of $13.23 and a low of $12.68.

What is the 52 week high and 52 week low for Lyell Immunopharma, Inc share?

Lyell Immunopharma, Inc share touched a 52 week high of $32 on and a 52 week low of $7.65 on . Lyell Immunopharma, Inc stock price today i.e. is closed at $12.85,which is 59.84% down from its 52 week high and 67.97% up from its 52 week low.

What is Lyell Immunopharma, Inc's market capitalisation today?

Lyell Immunopharma, Inc market capitalisation is $0.00T as on .

How to invest in Lyell Immunopharma, Inc Stock (LYEL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lyell Immunopharma, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lyell Immunopharma, Inc Shares that will get you 0.1167 shares as per Lyell Immunopharma, Inc share price of $12.85 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Lyell Immunopharma, Inc Stock (LYEL) from India?

Indian investors can start investing in Lyell Immunopharma, Inc (LYEL) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Lyell Immunopharma, Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Lyell Immunopharma, Inc share’s latest price of $12.85 as on September 13, 2025 at 1:29 am IST, you will get 0.7782 shares of Lyell Immunopharma, Inc. Learn more about fractional shares .